HAMILTON, Bermuda--(BUSINESS WIRE)--Covidien Ltd. (NYSE: COV; BSX: COV) today announced that a federal jury has ruled in favor of the Company in the patent litigation case Applied Medical Resources Corp. v. United States Surgical. The jury ruled that United States Surgical, a Covidien subsidiary, does not infringe Applied Medical’s U.S. Patent No. 5,385,553 related to trocar seal technology.
